Olatorepatide (Olatorepatidum) is a dual gastric inhibitory polypeptide ( GIP ) receptor and glucagon like peptide 1 ( GLP-1 ) receptor agonist, with antidiabetic effect [1].
References:
[1]. Olatorepatidum (Olatorepatide). WHO Drug Information, Vol. 37, No. 4, 2023.
References:
[1]. Olatorepatidum (Olatorepatide). WHO Drug Information, Vol. 37, No. 4, 2023.
















